Ultrasmall Polyphenol‐NAD + Nanoparticle‐Mediated Renal Delivery for Mitochondrial Repair and Anti‐Inflammatory Treatment of AKI‐to‐CKD Progression
Advanced Materials · 2024-07 · 36 (30)
DOI: 10.1002/adma.202310731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 14.06.2024. Verfasst von Ying Kong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Shandong First Medical University, NHC Key Laboratory of Biotechnology Drugs (Shandong Aca…. Hauptthemen laut MEDLINE: Acute Kidney Injury, NAD, Mitochondria, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
As a central metabolic molecule, nicotinamide adenine dinucleotide (NAD + ) can potentially treat acute kidney injury (AKI) and chronic kidney disease (CKD); however, its bioavailability is poor due to short half‐life, instability, the deficiency of targeting, and difficulties in transmembrane transport. Here a physiologically adaptive gallic acid‐NAD + nanoparticle is designed, which has ultrasmall size and pH‐responsiveness, passes through the glomerular filtration membrane to reach injured renal tubules, and efficiently delivers NAD + into the kidneys. With an effective accumulation in the kidneys, it restores renal function, immune microenvironment homeostasis, and mitochondrial homeostasis of AKI mice via the NAD + ‐Sirtuin‐1 axis, and exerts strong antifibrotic effects on the AKI‐to‐CKD transition by inhibiting TGF‐β signaling. It also exhibits excellent stability, biodegradable, and biocompatible properties, ensuring its long‐term safety, practicality, and clinical translational feasibility. The present study shows a potential modality of mitochondrial repair and immunomodulation through nanoagents for the efficient and safe treatment of AKI and CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital of Shandong First Medical University, NHC Key Laboratory of Biotechnology Drugs (Shandong Academy of Medical Sciences), Key Lab for Rare & Uncommon Diseases of Sha…
- State Key Laboratory of Crystal Materials, Shandong University, Jinan, 250100, Shandong, China.
- Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
- Department of Clinical Laboratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, Shandong, China.
- Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
- Department of Pharmacology, School of Basic Medical Science, Shandong University, Jinan, 250012, Shandong, China.
ORCID-Profile: Hong Liu
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Shandong Province
- Science and Technology Innovation 2030-Major Project
- Youth Innovation Team Plan in Colleges and Universities of Shandong Province
Zitieren
APA
Kong, Y., Chen, X., Liu, F., Tang, J., Zhang, Y., Zhang, X., Zhang, L., Zhang, T., Wang, Y., Su, M., Zhang, Q., Chen, H., Zhou, D., Yi, F., Liu, H., & Fu, Y. (2024). Ultrasmall Polyphenol‐NAD + Nanoparticle‐Mediated Renal Delivery for Mitochondrial Repair and Anti‐Inflammatory Treatment of AKI‐to‐CKD Progression. Advanced Materials, 36(30). https://doi.org/10.1002/adma.202310731
Vancouver
Kong Y, Chen X, Liu F, Tang J, Zhang Y, Zhang X, et al. Ultrasmall Polyphenol‐NAD + Nanoparticle‐Mediated Renal Delivery for Mitochondrial Repair and Anti‐Inflammatory Treatment of AKI‐to‐CKD Progression. Advanced Materials. 2024;36(30). doi:10.1002/adma.202310731
BibTeX
@article{Kong2024,
author = {Kong, Ying and Chen, Xu and Liu, Feng and Tang, Jiageng and Zhang, Yijing and Zhang, Xiangxiang and Zhang, Luyao and Zhang, Tong and Wang, Yaqi and Su, Mengxiao and Zhang, Qixin and Chen, Hanxiang and Zhou, Di and Yi, Fan and Liu, Hong and Fu, Yi},
title = {Ultrasmall Polyphenol‐NAD + Nanoparticle‐Mediated Renal Delivery for Mitochondrial Repair and Anti‐Inflammatory Treatment of AKI‐to‐CKD Progression},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {30},
doi = {10.1002/adma.202310731}
}
EUVIMED